D-0554-2026 Class II Ongoing

Recalled by Spectra Medical Devices, Llc — Wilmington, MA

FDA drug recall D-0554-2026 was initiated by Spectra Medical Devices, Llc on May 12, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 210625 ampules.

Recall details

Product Type
Drugs
Report Date
Jun 10, 2026
Initiation Date
May 12, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
210625 ampules

Product description

Lidocaine HCl Injection USP, 25x5 mL, Single-Dose Ampules, Rx Only, Distributed by: Spectra Medical Devices, LLC, Wilmington, Made in S. Korea, NDC 65282-1605-1.

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

USA Nationwide

Code information

Lot#: AE4013, Exp 1/31/2027; AE5032 & AE5039, Exp 3/31/2028; AE5104, Exp 8/31/2028.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0554-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0554-2026. Report a data issue: hello@regdatalab.com.